ATLANTA, GA – – (Newsfile Corp. – April 28, 2022) – – Holzer & Holzer, LLC is investigating whether Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC) complied with federal securities laws.  On April 27, 2022, Teladoc reported first quarter financial results for the quarter ended March 31, 2022. The Company announced it was revising and lowering its 2022 outlook due to a “lower-than-expected yield” on the Company’s marketing spend and a net loss per share of $41.58, which was attributed to a “non-cash goodwill impairment charge of $6.6 billion.” Following this announcement, the Company’s stock price dropped. If you purchased Teladoc stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at  or Joshua Karr, Esq. at, call our toll-free number at (888) 508-6832, or visit our website at to discuss your legal rights.

Provide Your Information To Take Action

  • Date PurchasedNumber of Shares AcquiredAcquisition Price Per Share 
  • Date SoldNumber of Shares SoldSelling Price Per Share 
  • Signed pursuant to the Uniform Electronic Transactions act as adopted by the various states and territories of the United States.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt